Prof. Dr. Steven Verhelst will supervise DC2 (Cleavable-linker bisubstrate FRET assays with covalent ATP anchors).
He received his PhD in Chemistry at Leiden University and performed post-doctoral research at the Stanford University, School of Medicine. He started his own laboratory at the Technical University Munich as an Emmy Noether group leader in 2008. In 2014, he moved to the Leibniz Institute for Analytical Sciences ISAS in Dortmund, Germany, as a group leader in chemical proteomics, a position that he kept until 2023. Since 2015, he is also appointed as associate professor in chemical biology at the Department of Cellular and Molecular Medicine of the University of Leuven, Belgium. He received tenure in 2017 and was promoted to full professor in 2024.
